Navid Mahmoodzadegan
Co-President, MD at Moelis & Company
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Moelis & Company, 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Moelis & Company June 25, 202699.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 19, 2025 | Moelis & Company | Option exercise | +57,009 | — | — |
| Feb 19, 2025 | Moelis & Company | Shares withheld for tax | −1 | $74.00 | $73 |
| Feb 19, 2025 | Moelis & Company | Open-market sale | −9,406 | $74.00 | $696,044 |
| Feb 18, 2025 | Moelis & Company | Option exercise | +150,000 | — | — |
| May 13, 2024 | Moelis & Company | Open-market sale | −44,980 | $54.92 | $2,470,302 |
| Mar 1, 2024 | Moelis & Company | Open-market sale | −19,483 | $53.88 | $1,049,744 |
| Feb 29, 2024 | Moelis & Company | Open-market sale | −50,772 | $54.11 | $2,747,273 |
| Feb 22, 2024 | Moelis & Company | Open-market sale | −10,402 | $54.92 | $571,278 |
| Feb 21, 2024 | Moelis & Company | Option exercise | +90,489 | — | — |
| Feb 21, 2024 | Moelis & Company | Option exercise | +87,143 | — | — |
| Feb 21, 2024 | Moelis & Company | Shares withheld for tax | −1 | $52.60 | $58 |
| Feb 21, 2024 | Moelis & Company | Open-market sale | −20,311 | $54.68 | $1,110,605 |
| Feb 21, 2024 | Moelis & Company | Open-market sale | −85,900 | $52.60 | $4,518,340 |
| Feb 20, 2024 | Moelis & Company | Open-market sale | −25,642 | $55.29 | $1,417,746 |
| Feb 16, 2024 | Moelis & Company | Open-market sale | −20,001 | $55.82 | $1,116,456 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.